Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04758780 |
|---|---|
| Brief Title: | Imaging Performance Assessment of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Metastatic Triple Negative Breast Cancer Patients (OPALESCENCE) |
| First Submitted : | January 14, 2021 |
| First Submitted that Met QC Criteria : | February 15, 2021 |
| First Posted : | February 17, 2021 |
| Last Update Submitted that Met QC Criteria : | February 20, 2023 |
| Last Update Posted : | February 21, 2023 |